Antiplatelet Therapy to Prevent Stroke in African Americans

This study has been completed.
Information provided by National Institute of Neurological Disorders and Stroke (NINDS)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Stroke
			Cerebral Infarction
2		Additional conditions recognized in this trial
			Infarction
3		More general conditions related to this trial
			Brain Diseases
			Brain Infarction
			Brain Ischemia
			Cardiovascular Diseases
			Central Nervous System Diseases
			Cerebrovascular Disorders
			Ischemia
			Necrosis
			Nervous System Diseases
			Pathologic Processes
			Vascular Diseases
4		Interventions listed in this trial
			aspirin
			ticlopidine
5		More general drug interventions related to this trial
			Analgesics
			Analgesics, Non-Narcotic
			Anti-Inflammatory Agents
			Anti-Inflammatory Agents, Non-Steroidal
			Antirheumatic Agents
			Cardiovascular Agents
			Central Nervous System Agents
			Cyclooxygenase Inhibitors
			Enzyme Inhibitors
			Fibrin Modulating Agents
			Fibrinolytic Agents
			Hematologic Agents
			Molecular Mechanisms of Pharmacological Action
			Peripheral Nervous System Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Platelet Aggregation Inhibitors
			Sensory System Agents
			Therapeutic Uses
6		Sponsors listed in this trial
			National Institute of Neurological Disorders and Stroke (NINDS)